TABLE 1.
IgM and IgG reactivity to NRA and SMB antigen in a panel of coded human serum specimensa
Specimen no. (day postonset) | ELISA titer
|
Nt antibody titer | |||||||
---|---|---|---|---|---|---|---|---|---|
IgM
|
IgG
|
||||||||
NRA | SMB
|
NRA | SMB
|
||||||
NY99 virus | Eg-101 virus | SLE virus | NY99 virus | Eg-101 virus | SLE virus | ||||
Positive control | 4.19 | 4.46 | 5.16 | 4.54 | 5.00 | 4.82 | ND | ||
1 (20) | 7.42 | 7.15 | 6.59 | 3.74 | 7.22 | 6.30 | 5.12 | 7.93 | 1:1,280 |
2 (14) | 4.26 | 3.12 | 4.34 | 1.14 | 1.14 | 1.31 | 1.40 | 1.8 | ND |
3 (16) | 6.00 | 5.39 | 6.18 | 2.08 | 1.61 | 1.85 | 1.95 | 2.53 | <1:10 |
4 (30) | 3.04 | 2.23 | 2.47 | 1.21 | 8.48 | 7.83 | 6.34 | ND | 1:160 |
5 (68) | 5.01 | 5.85 | 6.28 | 1.44 | 1.10 | 1.14 | 1.19 | 1.02 | ND |
6 (?) | 7.30 | 4.11 | 3.51 | 1.11 | 8.57 | 8.84 | 7.76 | 11.54 | 1:320 |
7 (43) | 1.90 | 1.76 | 2.69 | 0.79 | 7.82 | 7.66 | 6.40 | 3.61 | ND |
8 (20) | 1.12 | 0.98 | 0.95 | 0.91 | 1.53 | 1.64 | 1.70 | ND | ND |
9 (3) | 1.53 | 1.37 | 2.17 | 1.13 | 6.88 | 7.12 | 6.07 | ND | 1:5120 |
10 (3) | 6.43 | 4.69 | 6.04 | 1.87 | 3.94 | 4.23 | 4.38 | 2.31 | <1:10 |
11 (7) | 6.71 | 4.59 | 5.78 | 1.86 | 3.74 | 4.30 | 3.48 | 2.74 | 1:20 |
12 (10) | 1.14 | 1.06 | 1.17 | 0.96 | 6.30 | 6.59 | 5.11 | 7.28 | ND |
13 (?) | 1.13 | 0.90 | 1.13 | 1.33 | 1.20 | 1.38 | 1.41 | ND | ND |
14 (6) | 7.43 | 6.64 | 8.03 | 1.71 | 7.90 | 7.05 | 5.44 | 4.69 | 1:80 |
15 (3) | 7.44 | 6.98 | 8.32 | 2.89 | 2.96 | 3.04 | 2.43 | 2.44 | 1:160 |
16 (13) | 2.88 | 2.30 | 4.17 | 1.01 | 1.07 | 1.37 | 1.47 | 1.80 | <1:10 |
17 (4) | 1.20 | 0.85 | 0.90 | 1.07 | 0.94 | 1.34 | 1.34 | 1.49 | ND |
18 (8) | 1.09 | 0.97 | 1.01 | ND | 0.67 | 0.77 | 0.75 | ND | ND |
19 (73) | 1.04 | 0.96 | 0.95 | ND | 0.71 | 0.80 | 0.79 | ND | ND |
20 (8) | 1.10 | 1.14 | 1.01 | ND | 0.72 | 0.82 | 0.82 | ND | ND |
21 (0) | 1.06 | 0.92 | 0.88 | 0.91 | 0.79 | 0.88 | 1.11 | 0.90 | ND |
Total no. positive | 11 | 11 | 13 | 10 | 10 | 10 |
SLE virus MAC and IgG ELISAs were conducted as a separate test. Nt antibody titer was assayed in a 90% plaque reduction neutralization test against WN virus. ND, not done.